Noble Capital Markets Initiates Equity Research Coverage on Conduent Inc. (CDNT)
Noble’s Equity Research Analyst Patrick McCann launched coverage on Conduent Inc. today with his report titled "Peering Through The Fog Of Its Transition"
Noble Capital Markets Initiates Equity Research Coverage on SelectQuote (SLQT)
Noble’s Equity Research Analyst Patrick McCann launched coverage on SelectQuote today with his report titled “Can It Cut Loose Its Heavy Debt Anchor?"
Noble Capital Markets Initiates Equity Research Coverage on Unicycive Therapeutics (UNCY)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Unicycive Therapeutics today with his report titled “Initiating Coverage With An Outperform Rating"
Noble Capital Markets Served as Co-Manager to Kratos Defense & Security Solutions (KTOS) in $345mm Follow-on Offering
Noble Capital Markets is pleased to announce its role as Co-Manager in the completion of Kratos Defense & Security Solutions, Inc.’s recent underwritten follow-on offering of 16,666,667 shares of its common stock at a price of $18.00 per share. The transaction priced on February 22, 2024.
Noble Capital Markets Initiates Equity Research Coverage on ZyVersa Therapeutics (ZVSA)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on ZyVersa Therapeutics today with his report titled “Novel Therapies For Renal Diseases and Inflammation"
Noble Capital Markets Initiates Equity Research Coverage on Cadrenal Therapeutics (CVKD)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Cadrenal Therapeutics today with his report titled "Addressing Unmet Anticoagulation Needs In Orphan Populations"
Noble Capital Markets Served as a selling agent to The GEO Group (GEO) in At-The-Market Offering
Noble Capital Markets is pleased to announce its role as a sales agent in The GEO Group, Inc.’s recently announced at-the-market offering of common stock. Under the program, GEO may offer and sell shares having an aggregate offering price of up to $300 million from time to time through a syndicate of sales agents. The transaction was announced on December 28, 2023, pursuant to a shelf registration declared effective on October 30, 2023.
Noble Capital Markets Initiates Research Coverage on AdTheorent (ADTH)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on AdTheorent today with his report titled "Positioned To Outshine Favorable Industry Growth"
Noble Capital Markets Initiates Equity Research Coverage on Xcel Brands (XELB)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Xcel Brands today with his report titled “Likely To Be The Trough Toward Improved Results"
Noble Capital Markets Initiates Equity Research Coverage on Eledon Pharmaceuticals (ELDN)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Eledon Pharmaceuticals today with his report titled "Initiating Coverage With An Outperform Rating and $10 Price Target"
Noble Capital Markets Initiates Equity Research Coverage on QuantaSing Group Limited (QSG)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on QuantaSing Group today with his report titled "A Favorable Course For Revenue and Cash Flow Growth"
Noble Capital Markets Initiates Equity Research Coverage on Bitcoin Depot (BTM)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Bitcoin Depot today with his report titled "Initiating Coverage: Bringing Bitcoin To A "Store" Near You"